// App-Quantinova.ai

8563 : PD-L1 expression and tumor infiltrating lymphocytes (TIL) in brain metastases (BM) of small cell lung cancer (SCLC).

Researchers

Presenter

  • Anna Sophie Berghoff

Principal Investigators

  • Gerda Ricken

  • Dorothee Wilhelm

  • Orsolya Rajky

  • Georg Widhalm

  • Karin Dieckmann

  • Peter Birner

  • Rupert Bartsch

  • Christoph Zielinski

  • Matthias Preusser

Medical Centers

  • Medical University of Vienna, Vienna, Austria

  • Institute of Neurology, Medical University of Vienna, Vienna, Austria

  • Medical University of Vienna, Vienna, Austria

  • Department of Medicine I and Comprehensive Cancer Center CNS Tumours Unit, Medical University of Vienna, Austria, Vienna, Austria

  • Medical University of Vienna, Vienna, Austria

  • Department for Radiation Therapy and Radiation Biology, Medical University of Vienna, Vienna, Austria

  • Institute of Clinical Pathology and Comprehensive Cancer Center CNS Tumours Unit, Medical University of Vienna, Vienna, Austria

  • Department of Medicine I, Clinical Division of Oncology and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria

Locations

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Small cell lung cancer

  • Brain metastasis

  • Lung Cancer

  • Solid malignancies

Biomarkers

  • Cluster of Differentiation 2AP

  • Programmed cell death protein 1

  • Programmed death-ligand 1

  • Cluster of differentiation 8A

  • Forkhead Box P3

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved